SYDNEY, AUSTRALIA / ACCESSWIRE / March 7, 2023 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing...
SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company...
SYDNEY, AUSTRALIA / ACCESSWIRE / July 14, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing...
SYDNEY, AUSTRALIA / ACCESSWIRE / January 22, 2021 /Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing...
SYDNEY, AUSTRALIA / ACCESSWIRE / December 21, 2020 /Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing...